Gumimba, Earl Ian B.
HRN: 23-64-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/03/2023
09/09/2023
IV
4.5g
Q6
Sepsis Secondary To Infected Sacral Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes